|
 | Up a level |
Arora, Anjali and Somasundaram, Kumaravel (2019) Glioblastoma vs temozolomide: can the red queen race be won? In: CANCER BIOLOGY & THERAPY .
Arora, Anjali and Somasundaram, Kumaravel (2019) Targeted Proteomics Comes to the Benchside and the Bedside: Is it Ready for Us? In: BIOESSAYS, 41 (2).
Arora, Anjali and Tomar, Vivek Singh and Thomas, Sannu and Patil, Vikas and Hoheisel, Joerg and Somasundaram, Kumaravel (2018) Pooled shRNA screen uncovered the role of SEL1L, an ERAD (endoplasmic reticulum associated degradation) gene, in modulating temozolomide resistance in GBM. In: CANCER RESEARCH, 78 (13, S).
Nawaz, Zahid and Patil, Vikas and Arora, Anjali and Hegde, Alangar S and Arivazhagan, Arimappamagan and Santosh, Vani and Somasundaram, Kumaravel (2016) Cbx7 is epigenetically silenced in glioblastoma and inhibits cell migration by targeting YAP/TAZ-dependent transcription. In: SCIENTIFIC REPORTS, 6 .
